Weill Medical College of Cornell University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).

701 total trials 127 currently recruiting 387 completed early-phase tilt top decile by trial count

Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.

Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.

Top-decile sponsor footprint

Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 27/100

387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

701 total, page 1 of 15

RECRUITING NA

Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)

NCT06118983

RECRUITING Phase 4

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

NCT07257484

RECRUITING NA

Decision Support Tool for Patients With Advanced Breast Cancer

NCT07635147

RECRUITING NA

Intrauterine Stent Placement Following Hysteroscopic Septum Resection

NCT07032506

RECRUITING NA

Regular Diet After Colorectal Surgery

NCT07540845

RECRUITING NA

Digital Tools to Support Healthcare Decision Making

NCT07485725

RECRUITING Phase 2

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

NCT07553338

RECRUITING NA

Trial to Test the Effectiveness of Vibrotactile Stimulation for Lower Limb Spasticity

NCT07447934

RECRUITING NA

The Relationship Between Blood Flow Readings During Surgery and How Well the Graft Stays Open and How Patients Recover Afterward in Coronary Artery Bypass Graft Surgery

NCT07485738

RECRUITING NA

Trial of Spiritual Care Interventions for Patients With Cancer

NCT07408310

RECRUITING NA

Using Middle School Science Teachers to Address Cancer Health Disparities

NCT07501689

RECRUITING NA

Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being

NCT07222696

RECRUITING Phase 3

Optimizing Pain Treatment in Children On Mechanical Ventilation

NCT06994442

RECRUITING NA

Integrated PTSD and Chronic Pain Treatment

NCT07225049

RECRUITING NA

Improving the Heart Health of Home Health Aides

NCT07067398

RECRUITING

Diffusion MRI for Quantitative Assessment of Myofascial Pain

NCT06892041

RECRUITING NA

Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening

NCT07052266

RECRUITING NA

Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices

NCT06168058

RECRUITING NA

Affect of Melatonin on Sleep and Cognition in Cirrhosis

NCT07046429

RECRUITING NA

TAP Block Timing Study

NCT07064200

RECRUITING NA

PENG vs Femoral Block for Hip Fracture Analgesia

NCT07073209

RECRUITING NA

Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.

NCT06990724

RECRUITING NA

Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients

NCT06975059

RECRUITING NA

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

NCT06811389

RECRUITING Phase 3

Two Versus One Week Breast Radiotherapy (RT)

NCT06960707

RECRUITING Phase 2

Luspatercept for Clonal Cytopenias of Uncertain Significance

NCT06788691

RECRUITING

Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

NCT07413211

RECRUITING Phase 1

Gene Therapy for Alpha 1- Antitrypsin Deficiency

NCT06996756

RECRUITING NA

Mobile Cognitive Behavioral Therapy for Stroke

NCT06689878

RECRUITING Phase 2

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

NCT06623656

RECRUITING NA

Pilot Trial of Spiritual Care Interventions for Patients With Cancer

NCT06811376

RECRUITING NA

Improving the Mental Health of Home Health Aides

NCT06071221

RECRUITING Phase 4

Split Face Study of the Duration of Local Anesthetics - Fourth Arm

NCT06694714

RECRUITING NA

Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions

NCT06743789

RECRUITING Phase 4

Calcium Carbonate to Augment Labor Contractions

NCT06580782

RECRUITING NA

Living Memory Home-4-Dementia Care Pairs

NCT06225986

RECRUITING Phase 4

Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study

NCT06433310

RECRUITING Phase 3

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

NCT06274554

RECRUITING NA

Implementation of IVS3 for Upper Limb Motor Recovery

NCT06483230

RECRUITING Phase 3

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

NCT06399705

RECRUITING Phase 3

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

NCT06399692

RECRUITING Phase 1

E-CEL UVEC Treatment for Anal Fissures

NCT06456073

RECRUITING

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

NCT06647511

RECRUITING Phase 4

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

NCT06377371

RECRUITING Phase 3

One-Month DAPT in CABG Patients

NCT05997693

RECRUITING NA

Personalized Mobile Cognitive Behavioral Therapy Application

NCT05699525

RECRUITING NA

Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair

NCT06444347

RECRUITING Phase 2

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

NCT06340711

RECRUITING NA

Psychosocial Support for Patients With Takotsubo Syndrome

NCT05977049

RECRUITING NA

JessieHug Feasibility and Usability Assessment

NCT06466148

Page 1 of 15 Next →

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 111
Phase 3 26
Phase 4 63

What is open in the Weill Medical College of Cornell University pipeline

127 recruiting of 701 indexed (18% open); 387 completed (55%).

Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).

Top condition: Prostate Cancer (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Weill Medical College of Cornell University: open-pipeline peers nationwide

Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 5%10%15%20%25% Total trials Recruiting share Weill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiSanofiThe Cleveland ClinicUniversity of MiamiChildren's Hospital of PhiladelphiaUniversity of California, BerkeleyBurke Medical Research InstituteGrand Valley State University
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 701 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this Weill Medical College of Cornell University page

701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.

  • 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets.Report a data error.